PALATIN TECHNOLOGIES, INC. Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments
PALATIN TECHNOLOGIES, INC. (PTN) reported Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments of $119.35 thousand for the 12-month period ending 2011-06-30, per its 10-K filed 2012-09-10.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2012-09-10
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2011-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2011 was $119.35K.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 3 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 9 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 12 month |
|---|---|---|---|
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-10 | $119.35K 10-K · filed 2012-09-10 | |
| 2011-03-31 | $119.35K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |